ArticleDrug design, development and therapy2021

Maackiain Protects the Kidneys of Type 2 Diabetic Rats via Modulating the Nrf2/HO-1 and TLR4/NF-κB/Caspase-3 Pathways.

Jiahong Guo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.